Miami, USA | May 17-19 2017

SynapCell to unveil unprecedented advances in Epilepsy at the Antiepileptic Drug Trials Conference.
Contact us to select a convenient time for you to meet Corinne, CEO and founder of SynapCell.

Conference Purpose

  • The conference focuses on issues surrounding AEDD development, ranging from preclinical discoveries to clinical evaluations. Topics to be covered at the conference include:
  • The processes by which new drugs are discovered, including discussing new animal models and molecular targets
  • Translational models in the epilepsy space
  • New regulatory pathways for epilepsy approval, including orphan indications, and extrapolation from adults to children
  • Assessing patient suitability for epilepsy trials, including centralized patient interviews
  • New objectives and legislation that have an impact on AED development
  • Novel trial designs that reduce placebo exposure
  • New methods and devices for seizure counting
  • Outlining the drugs and devices in preclinical and clinical development for epilepsy

Find out more information on the Epilepsy Foundation website!